Marijuana not ready for prime time as an analgesic

General Hospital Psychiatry

Volumn 36, Issue 1, 2014, Pages 4-6

  Saxon, Andrew J ^a,b   Browne, Kendall W ^a,c  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID;

ADVERSE OUTCOME; ANALGESIA; CANNABIS USE; CHEMICAL COMPOSITION; CHRONIC PAIN; DECISION MAKING; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; EMOTIONALITY; HUMAN; MEMORY CONSOLIDATION; NONHUMAN; PAIN ASSESSMENT; RECALL; RISK ASSESSMENT; SUICIDAL IDEATION; WORKING MEMORY;

ANALGESICS; CHRONIC PAIN; COGNITION DISORDERS; DEPRESSIVE DISORDER; HUMANS; MARIJUANA ABUSE; MEDICAL MARIJUANA; PSYCHOTIC DISORDERS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 84891276622     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2013.08.005     Document Type: Editorial

References (43)

1. Borgelt L.M., Franson K.L., Nussbaum A.M., Wang G.S. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013, 33:195-209.
2. Hill A.J., Williams C.M., Whalley B.J., Stephens G.J. Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther Jan 2012, 133:79-97.
3. Ohlsson A., Lindgren J.E., Wahlen A., Agurell S., Hollister L.E., et al. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther Sep 1980, 28:409-416.
4. Heishman S.J., Huestis M.A., Henningfield J.E., Cone E.J. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav 1990, 37:561-565.
5. Wilson W.H., Ellinwood E.H., Mathew R.J., Johnson K. Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res 1994, 51:115-125.
6. Cooper Z.D., Haney M. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry 2009, 21:104-112.
7. Martin-Santos R., Crippa J.A., Batalla A., et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des 2012, 18:4966-4979.
8. Mechoulam R., Peters M., Murillo-Rodriguez E., Hanus L.O. Cannabidiol-recent advances. Chem Biodivers 2007, 4:1678-1692.
9. Leweke F.M., Piomelli D., Pahlisch F., et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012, 2:e94.
10. Tsumura Y., Aoki R., Tokieda Y., et al. A survey of the potency of Japanese illicit cannabis in fiscal year 2010. Forensic Sci Int 2012, 221:77-83.
11. Moreira F.A., Lutz B. The endocannabinoid system: emotion, learning and addiction. Addict Biol 2008, 13:196-212.
12. Mechoulam R., Parker L.A. The endocannabinoid system and the brain. Annu Rev Psychol 2013, 64:21-24.
13. Herkenham M., Lynn A.B., Little M.D., et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990, 87:1932-1936.
14. Di Marzo V. Targeting the endocannabinoid system: to enhance or reduceα. Nat Rev Drug Discov May 2008, 7(5):438-455.
15. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 2008, 1:81-98.
16. Solowij N., Jones K.A., Rozman M.E., et al. Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology (Berl) 2011, 216:131-144.
17. Honarmand K., Tierney M.C., O'Connor P., Feinstein A. Effects of cannabis on cognitive function in patients with multiple sclerosis. Neurology 2011, 76:1153-1160.
18. Bolla K.I., Brown K., Eldreth D., Tate K., Cadet J.L. Dose-related neurocognitive effects of marijuana use. Neurology 2002, 59:1337-1343.
19. Hartman R.L., Huestis M.A. Cannabis effects on driving skills. Clin Chem 2013, 59:478-492.
20. Crean R.D., Crane N.A., Mason B.J. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011, 5:1-8.
21. Knaster P., Karlsson H., Estlander A.M., Kalso E. Psychiatric disorders as assessed with SCID in chronic pain patients: the anxiety disorders precede the onset of pain. Gen Hosp Psychiatry 2012, 34:46-52.
22. van Laar M., van Dorsselaer S., Monshouwer K., de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult populationα. Addiction 2007, 102(8):1251-1260.
23. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002, 325:1199-1203.
24. Horwood L.J., Fergusson D.M., Coffey C., et al. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend 2012, 126:369-378.
25. Henquet C., van Os J., Kuepper R., et al. Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry 2010, 196:447-453.
26. Foti D.J., Kotov R., Guey L.T., Bromet E.J. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry 2010, 167:987-993.
27. Baethge C., Hennen J., Khalsa H.M., Salvatore P., Tohen M., Baldessarini R.J. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord 2008, 10:738-741.
28. van Rossum I., Boomsma M., Tenback D., Reed C., van Os J. Does cannabis use affect treatment outcome in bipolar disorderα A longitudinal analysis. J Nerv Ment Dis 2009, 197:35-40.
29. van Ours J.C., Williams J., Fergusson D., Horwood L.J. Cannabis use and suicidal ideation. J Health Econ 2013, 32:524-537.
30. Nussbaum A., Thurstone C., Binswanger I. Medical marijuana use and suicide attempt in a patient with major depressive disorder. Am J Psychiatry 2011, 168:778-781.
31. Fadda P., Scherma M., Spano M.S., et al. Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 2006, 17:1629-1632.
32. Bossong M.G., van Berckel B.N., Boellaard R., et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009, 34:759-766.
33. Elkashef A., Vocci F., Huestis M., et al. Marijuana neurobiology and treatment. Subst Abus 2008, 29:17-29.
34. Pletcher M.J., Vittinghoff E., Kalhan R., et al. Association between marijuana exposure and pulmonary function over 20years. JAMA 2012, 307:173-181.
35. Aldington S., Williams M., Nowitz M., et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007, 62:1058-1063.
36. Tashkin D.P. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis 2005, 63:93-100.
37. Caldicott D.G., Holmes J., Roberts-Thomson K.C., Mahar L. Keep off the grass: marijuana use and acute cardiovascular events. Eur J Emerg Med 2005, 12:236-244.
38. Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., Muller J.E. Triggering myocardial infarction by marijuana. Circulation 2001, 103:2805-2809.
39. Bachs L., Morland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 2001, 124:200-203.
40. Turcotte D., Le Dorze J.A., Esfahani F., Frost E., Gomori A., Namaka M. Examining the roles of cannabinoids in pain and other therapeutic indications: a review. Expert Opin Pharmacother 2010, 11:17-31.
41. Cooper ZD, Comer SD, Haney M. Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers. Neuropsychopharmacology. (in press).
42. Nurmikko T.J., Serpell M.G., Hoggart B., Toomey P.J., Morlion B.J., Haines D. Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 2007, 133:210-220.
43. Frank B., Serpell M.G., Hughes J., Matthews J.N., Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ 2008, 336:199-201.